Affordability of adult tuberculosis vaccination in India and China: A dynamic transmission model-based analysisFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
BCG and new preventive tuberculosis vaccines: Implications for healthcare workers.Friday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
The health and economic benefits possible with novel tuberculosis vaccines – A modeling study in India and IndonesiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and IndiaFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Friday, August 9, 2024Availability, Epidemiological impactRead More
ACEITar: Evaluation of the acceptability of new and repurposed tuberculosis vaccines in Mozambique Friday, August 9, 2024Acceptability, Acceptability and demandRead More
Formative work to understand factors affecting future TB vaccines acceptanceFriday, August 9, 2024Acceptability, Acceptability and demand, Acceptability and demand, Accessibility, Health system readiness, Health system readinessRead More
Estimating the epidemiologic impact of new TB vaccines in high-burden settingsFriday, August 9, 2024Availability, Epidemiological impactRead More
Estimating the epidemiologic impact of new TB vaccines in the U.S.Friday, August 9, 2024Availability, Epidemiological impactRead More
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
